ICCC
vs
ABBV
ICCC
ABBV
Over the past 12 months, ICCC has underperformed ABBV, delivering a return of +17% compared to the ABBV's +18% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ICCC
ABBV
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
ImmuCell Corp
NASDAQ:ICCC
|
6.38
USD
|
|||||
|
Abbvie Inc
NYSE:ABBV
|
223.84
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ICCC, ABBV
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
ImmuCell Corp
Revenue
|
|||||||||||
|
Abbvie Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ICCC, ABBV
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
ImmuCell Corp
NASDAQ:ICCC
|
|||||||||
|
Abbvie Inc
NYSE:ABBV
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ICCC, ABBV
Performance By Year
ICCC, ABBV
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.